Literature DB >> 18036792

An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol.

Sheng Qi1, Paolo Avalle, Robert Saklatvala, Duncan Q M Craig.   

Abstract

The effects of thermal history and sample preparation on the polymorphic transformation profile from amorphous paracetamol have been investigated. The crystallisation behaviour of slow and quench cooled amorphous paracetamol was studied using DSC. Quench cooled paracetamol showed a glass transition (Tg) at 25.2 degrees C, a single exothermic transition at 64.9 degrees C and an endotherm at 167.7 degrees C. The initial degree of crystallinity was calculated as a function of time and recrystallisation circa 20 degrees C below Tg was demonstrated. Slow cooled material in pinholed or hermetic pans (sealed under nitrogen) showed a Tg at 25.1 degrees C, two exothermic transitions at circa 80-85 degrees C and 120-130 degrees C followed by melting at 156.9 degrees C; a single exotherm at 83 degrees C was observed for material sealed in hermetic pans under ambient conditions. Hot stage microscopy yielded complementary information on crystal growth and transformation profile. A transformation scheme is proposed which indicates that amorphous paracetamol may transform into Form III, II or I depending on the thermal history and the gaseous environment in which recrystallisation takes place. The study has demonstrated that the thermal history and encapsulation method may profoundly influence the polymorphic forms generated from amorphous paracetamol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036792     DOI: 10.1016/j.ejpb.2007.10.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  The Development of Direct Extrusion-Injection Moulded Zein Matrices as Novel Oral Controlled Drug Delivery Systems.

Authors:  Jacob Bouman; Peter Belton; Paul Venema; Erik van der Linden; Renko de Vries; Sheng Qi
Journal:  Pharm Res       Date:  2015-03-17       Impact factor: 4.200

2.  Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.

Authors:  Ziyi Yang; Kathrin Nollenberger; Jessica Albers; Duncan Craig; Sheng Qi
Journal:  Pharm Res       Date:  2014-10-01       Impact factor: 4.200

3.  Development of sustained-release formulations processed by hot-melt extrusion by using a quality-by-design approach.

Authors:  Muhammad T Islam; Mohammed Maniruzzaman; Sheelagh A Halsey; Babur Z Chowdhry; Dennis Douroumis
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

4.  Quantification of Process Induced Disorder in Milled Samples Using Different Analytical Techniques.

Authors:  Ulrike Zimper; Jaakko Aaltonen; Cushla M McGoverin; Keith C Gordon; Karen Krauel-Goellner; Thomas Rades
Journal:  Pharmaceutics       Date:  2010-02-16       Impact factor: 6.321

5.  Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.

Authors:  Ecaterina Bordos; Muhammad T Islam; Alastair J Florence; Gavin W Halbert; John Robertson
Journal:  Mol Pharm       Date:  2019-09-09       Impact factor: 4.939

6.  Detection of the Crystallization Process of Paracetamol with a Multi-Mode Optical Fiber in a Reflective Configuration.

Authors:  Liliana Soares; Susana Novais; António Ferreira; Orlando Frazão; Susana Silva
Journal:  Sensors (Basel)       Date:  2019-12-22       Impact factor: 3.576

7.  Crystallization and phase changes in paracetamol from the amorphous solid to the liquid phase.

Authors:  Juraj Sibik; Michael J Sargent; Miriam Franklin; J Axel Zeitler
Journal:  Mol Pharm       Date:  2014-03-13       Impact factor: 4.939

8.  ζ-Glycine: insight into the mechanism of a polymorphic phase transition.

Authors:  Craig L Bull; Giles Flowitt-Hill; Stefano de Gironcoli; Emine Küçükbenli; Simon Parsons; Cong Huy Pham; Helen Y Playford; Matthew G Tucker
Journal:  IUCrJ       Date:  2017-09-01       Impact factor: 4.769

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.